Author:
Faraci M, ,Békássy A N,De Fazio V,Tichelli A,Dini G
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference55 articles.
1. www.survivorsshipguidelines.org , 2006.
2. Toubert A . Immune reconstitution after allogeneic HSCT. In: Apperley J, Carreras E, Gluckman E, Gratwohl A, Masszi T (eds). The EBMT Handbook. Haematopoietic Stem Cell Transplantation, 2004 revised edn. European School of Haematology, France, 2004, pp 215–222.
3. Socié G, Salooja N, Cohen A, Rovelli A, Carreras E, Locasciulli A et al. Nonmalignant late effects after allogeneic stem cell transplantation. Blood 2003; 101: 3373–3385.
4. Castagnola E, Dallorso S, Faraci M, Morreale G, Di Martino D, Cristina E et al. Long lasting Hypogammaglobulinemia following rituximab administration for Epstein–Barr virus-related post-transplant lymphoproliferative disease preemptive therapy. J Hematother Stem Cell Res 2003; 12: 9–10.
5. Rizzo JD, Wingard JR, Tichelli A, Lee SJ, Van Lint MT, Burns LJ et al. Recommended screening and preventive practices for long-term survivors after haematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Centre for International, Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT). Bone Marrow Transplant 2006; 37: 249–261.
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献